GlassScriptPhysician profile
David R Friedmann
NPI 1063656296
$10,790.26
in general payments reported to CMS, 2019-2025
9 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,897 · 2020: $46.38 · 2021: $1,498 · 2022: $1,911 · 2023: $2,812 · 2024: $1,446 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,786 · Consulting Fee: $1,500 · Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,785.83 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,151.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $8,103.53 | 2019-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Med-El Corporation | $1,169.77 | 2023-2024 | Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit, Bci 602 Kit |
| Vertex Pharmaceuticals Incorporated | $457.50 | 2019 | |
| Iotamotion, INC. | $420.58 | 2022-2023 | Iotasoft Insertion System |
| Nobelpharma America, LLC | $216.00 | 2023 | |
| Advanced Bionics, LLC | $196.35 | 2020-2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Oticon Medical, LLC | $172.58 | 2021 | |
| Integra Lifesciences Corporation | $36.21 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Novartis Pharmaceuticals Corporation | $17.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Friedmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.